Global mRNA Platform Market Growth (Status and Outlook) 2024-2030

Publication ID:

LPI06243044

Publication Date:

June 14, 2024

Pages:

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global mRNA Platform market size was valued at US$ million in 2023. With growing demand in downstream market, the mRNA Platform is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.
The research report highlights the growth potential of the global mRNA Platform market. mRNA Platform are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of mRNA Platform. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the mRNA Platform market.
The mRNA platform refers to a technology and method used for vaccine development and gene therapy. mRNA, or messenger RNA, is a single-stranded molecule that carries genetic information from DNA to the ribosomes in cells, where it is translated into proteins. In the mRNA platform, synthetic mRNA molecules containing the genetic code for a specific protein are delivered into cells to instruct them to produce that protein.
Key Features:
The report on mRNA Platform market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the mRNA Platform market. It may include historical data, market segmentation by Type (e.g., Infectious Disease Vaccines, Cancer Vaccines), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the mRNA Platform market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the mRNA Platform market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the mRNA Platform industry. This include advancements in mRNA Platform technology, mRNA Platform new entrants, mRNA Platform new investment, and other innovations that are shaping the future of mRNA Platform.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the mRNA Platform market. It includes factors influencing customer ' purchasing decisions, preferences for mRNA Platform product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the mRNA Platform market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting mRNA Platform market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the mRNA Platform market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the mRNA Platform industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the mRNA Platform market.
Market Segmentation:
mRNA Platform market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
Infectious Disease Vaccines
Cancer Vaccines
Segmentation by application
Infectious Disease
Cancer
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Arcturus Therapeutic
Argos Therapeutics
BioNTec
CureVac
Etherna
Ethris
GlaxoSmithKline
Pfizer
Translate Bio

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global mRNA Platform Market Size 2019-2030
2.1.2 mRNA Platform Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 mRNA Platform Segment by Type
2.2.1 Infectious Disease Vaccines
2.2.2 Cancer Vaccines
2.3 mRNA Platform Market Size by Type
2.3.1 mRNA Platform Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global mRNA Platform Market Size Market Share by Type (2019-2024)
2.4 mRNA Platform Segment by Application
2.4.1 Infectious Disease
2.4.2 Cancer
2.5 mRNA Platform Market Size by Application
2.5.1 mRNA Platform Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global mRNA Platform Market Size Market Share by Application (2019-2024)
3 mRNA Platform Market Size by Player
3.1 mRNA Platform Market Size Market Share by Players
3.1.1 Global mRNA Platform Revenue by Players (2019-2024)
3.1.2 Global mRNA Platform Revenue Market Share by Players (2019-2024)
3.2 Global mRNA Platform Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 mRNA Platform by Regions
4.1 mRNA Platform Market Size by Regions (2019-2024)
4.2 Americas mRNA Platform Market Size Growth (2019-2024)
4.3 APAC mRNA Platform Market Size Growth (2019-2024)
4.4 Europe mRNA Platform Market Size Growth (2019-2024)
4.5 Middle East & Africa mRNA Platform Market Size Growth (2019-2024)
5 Americas
5.1 Americas mRNA Platform Market Size by Country (2019-2024)
5.2 Americas mRNA Platform Market Size by Type (2019-2024)
5.3 Americas mRNA Platform Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC mRNA Platform Market Size by Region (2019-2024)
6.2 APAC mRNA Platform Market Size by Type (2019-2024)
6.3 APAC mRNA Platform Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe mRNA Platform by Country (2019-2024)
7.2 Europe mRNA Platform Market Size by Type (2019-2024)
7.3 Europe mRNA Platform Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa mRNA Platform by Region (2019-2024)
8.2 Middle East & Africa mRNA Platform Market Size by Type (2019-2024)
8.3 Middle East & Africa mRNA Platform Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global mRNA Platform Market Forecast
10.1 Global mRNA Platform Forecast by Regions (2025-2030)
10.1.1 Global mRNA Platform Forecast by Regions (2025-2030)
10.1.2 Americas mRNA Platform Forecast
10.1.3 APAC mRNA Platform Forecast
10.1.4 Europe mRNA Platform Forecast
10.1.5 Middle East & Africa mRNA Platform Forecast
10.2 Americas mRNA Platform Forecast by Country (2025-2030)
10.2.1 United States mRNA Platform Market Forecast
10.2.2 Canada mRNA Platform Market Forecast
10.2.3 Mexico mRNA Platform Market Forecast
10.2.4 Brazil mRNA Platform Market Forecast
10.3 APAC mRNA Platform Forecast by Region (2025-2030)
10.3.1 China mRNA Platform Market Forecast
10.3.2 Japan mRNA Platform Market Forecast
10.3.3 Korea mRNA Platform Market Forecast
10.3.4 Southeast Asia mRNA Platform Market Forecast
10.3.5 India mRNA Platform Market Forecast
10.3.6 Australia mRNA Platform Market Forecast
10.4 Europe mRNA Platform Forecast by Country (2025-2030)
10.4.1 Germany mRNA Platform Market Forecast
10.4.2 France mRNA Platform Market Forecast
10.4.3 UK mRNA Platform Market Forecast
10.4.4 Italy mRNA Platform Market Forecast
10.4.5 Russia mRNA Platform Market Forecast
10.5 Middle East & Africa mRNA Platform Forecast by Region (2025-2030)
10.5.1 Egypt mRNA Platform Market Forecast
10.5.2 South Africa mRNA Platform Market Forecast
10.5.3 Israel mRNA Platform Market Forecast
10.5.4 Turkey mRNA Platform Market Forecast
10.5.5 GCC Countries mRNA Platform Market Forecast
10.6 Global mRNA Platform Forecast by Type (2025-2030)
10.7 Global mRNA Platform Forecast by Application (2025-2030)

11 Key Players Analysis
11.1 Arcturus Therapeutic
11.1.1 Arcturus Therapeutic Company Information
11.1.2 Arcturus Therapeutic mRNA Platform Product Offered
11.1.3 Arcturus Therapeutic mRNA Platform Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Arcturus Therapeutic Main Business Overview
11.1.5 Arcturus Therapeutic Latest Developments
11.2 Argos Therapeutics
11.2.1 Argos Therapeutics Company Information
11.2.2 Argos Therapeutics mRNA Platform Product Offered
11.2.3 Argos Therapeutics mRNA Platform Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Argos Therapeutics Main Business Overview
11.2.5 Argos Therapeutics Latest Developments
11.3 BioNTec
11.3.1 BioNTec Company Information
11.3.2 BioNTec mRNA Platform Product Offered
11.3.3 BioNTec mRNA Platform Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 BioNTec Main Business Overview
11.3.5 BioNTec Latest Developments
11.4 CureVac
11.4.1 CureVac Company Information
11.4.2 CureVac mRNA Platform Product Offered
11.4.3 CureVac mRNA Platform Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 CureVac Main Business Overview
11.4.5 CureVac Latest Developments
11.5 Etherna
11.5.1 Etherna Company Information
11.5.2 Etherna mRNA Platform Product Offered
11.5.3 Etherna mRNA Platform Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Etherna Main Business Overview
11.5.5 Etherna Latest Developments
11.6 Ethris
11.6.1 Ethris Company Information
11.6.2 Ethris mRNA Platform Product Offered
11.6.3 Ethris mRNA Platform Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Ethris Main Business Overview
11.6.5 Ethris Latest Developments
11.7 GlaxoSmithKline
11.7.1 GlaxoSmithKline Company Information
11.7.2 GlaxoSmithKline mRNA Platform Product Offered
11.7.3 GlaxoSmithKline mRNA Platform Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 GlaxoSmithKline Main Business Overview
11.7.5 GlaxoSmithKline Latest Developments
11.8 Pfizer
11.8.1 Pfizer Company Information
11.8.2 Pfizer mRNA Platform Product Offered
11.8.3 Pfizer mRNA Platform Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Pfizer Main Business Overview
11.8.5 Pfizer Latest Developments
11.9 Translate Bio
11.9.1 Translate Bio Company Information
11.9.2 Translate Bio mRNA Platform Product Offered
11.9.3 Translate Bio mRNA Platform Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Translate Bio Main Business Overview
11.9.5 Translate Bio Latest Developments
12 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂